procyanidin b2 has been researched along with imiquimod in 1 studies
| Studies (procyanidin b2) | Trials (procyanidin b2) | Recent Studies (post-2010) (procyanidin b2) | Studies (imiquimod) | Trials (imiquimod) | Recent Studies (post-2010) (imiquimod) |
|---|---|---|---|---|---|
| 208 | 3 | 155 | 3,264 | 284 | 1,963 |
| Protein | Taxonomy | procyanidin b2 (IC50) | imiquimod (IC50) |
|---|---|---|---|
| Histamine H2 receptor | Homo sapiens (human) | 1.506 | |
| Alpha-1D adrenergic receptor | Homo sapiens (human) | 2.621 | |
| Adenosine receptor A2a | Homo sapiens (human) | 5.32 | |
| 7,8-dihydro-8-oxoguanine triphosphatase | Homo sapiens (human) | 0.646 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Endo, K; Makabe, H; Nakashima, A; Sawa, T; Tanaka, S; Tanaka, Y | 1 |
1 other study(ies) available for procyanidin b2 and imiquimod
| Article | Year |
|---|---|
Procyanidin B2 3,3''-di-O-gallate ameliorates imiquimod-induced skin inflammation by suppressing TLR7 signaling through the inhibition of endosomal acidification in dendritic cells.
Topics: Animals; Cytokines; Dendritic Cells; Dermatitis; Endosomes; Hydrogen-Ion Concentration; Imiquimod; Inflammation; Mice; Toll-Like Receptor 7 | 2023 |